Document:

Exhibit 10.2

 

DIPLOMAT PHARMACY, INC.

Form of Stock Option Award Agreement

Under 2014 Omnibus Incentive Plan

 

1.             Grant of Option.  Pursuant to the Diplomat Pharmacy, Inc. 2014 Omnibus Incentive Plan (the “Plan”), effective as of the Grant Date set forth above, Diplomat Pharmacy, Inc. (the “Company”) grants to the Grantee identified above an option (the “Option”) to purchase up to (but not in excess of)        shares of the Company’s common stock, no par value (the “Option Shares”), at the Exercise Price per Option Share set forth above, on the terms and subject to the conditions set forth in this Stock Option Award Agreement (this “Agreement”) and in the Plan. The Option is intended to be a Non-qualified Stock Option. Capitalized terms not defined in this Agreement have the meanings ascribed to such terms in the Plan.

 

2.             Term of Option.  The Option shall expire on the ten year anniversary of the Grant Date (the “Expiration Date”), subject to earlier expiration following termination of the Grantee’s employment with the Company or a Subsidiary as provided in Paragraph 6 below.

 

3.             Normal Vesting.   Grantee may exercise the Option only if and to the extent that the Option has become vested. For this purpose and except as provided in Paragraphs 4  and 6  below, the Option shall become vested         , provided that the Option shall cease vesting upon termination of Grantee’s employment with the Company or a Subsidiary for any reason whatsoever and the portion of the Option scheduled to vest on any such vesting date shall vest only if Grantee has remained continuously employed by the Company or a Subsidiary from the Grant Date to such vesting date.

 

4.             Accelerated Vesting upon Termination after Change in Control. Notwithstanding Paragraph 3 above, upon the termination without Cause by the Company or a Subsidiary (or a successor, as applicable) of Grantee’s service as an employee or if Grantee resigns for Good Reason (as defined below) in connection with or within one year following the consummation of a Change in Control, then the vesting of this Option shall accelerate such that 100% of the Option Shares then unvested shall vest, effective immediately prior to such termination of Grantee’s employment.  In the event of a Change in Control, if the Company’s successor (which, for the purposes of this provision, is the acquirer of the Company’s assets in a Change in Control resulting from the sale of all or substantially all of the Company’s assets) does not agree to assume this Option, or to substitute an equivalent award or right for this Option, and if Grantee has remained continuously employed from the Grant Date to the date of the Change in Control, and does not voluntarily resign without continuing with the Company’s successor, then the vesting of Option Shares shall accelerate such that this Option shall be vested to the same extent as if Grantee had been terminated without Cause as described above, effective immediately prior to, and contingent upon, the consummation of such Change in Control.  In the event the Option accelerates pursuant to this Paragraph 4, any portion of the Option that is vested or accelerated on such date may be exercised only during the one year period following such termination, but in no event after the Expiration Date.

 

 

As used herein, “Good Reason” shall mean Grantee’s resignation due to the occurrence of any of the following conditions which occurs without Grantee’s written consent, provided that the requirements regarding advance notice and an opportunity to cure set forth below are satisfied:  (1) a reduction of Grantee’s then current base salary by 10% or more unless such reduction is part of a generalized salary reduction affecting similarly situated employees; (2) a change in Grantee’s position with the Company that materially reduces Grantee’s duties, level of authority or responsibility; (3) a material breach of any employment agreement between Grantee and the Company or a Subsidiary (if any); or (4) the Company conditions Grantee’s continued service with the Company on Grantee’s being transferred to a site of employment that would increase Grantee’s one-way commute by more than 50 miles from Grantee’s then principal residence.  In order for Grantee to resign for Good Reason, Grantee must provide written notice to the Company of the existence of the Good Reason condition within 30 days of the initial existence of such Good Reason condition.  Upon receipt of such notice, the Company will have 30 days during which it may remedy the Good Reason condition and not be required to provide for the vesting acceleration described herein as a result of such proposed resignation.  If the Good Reason condition is not remedied within such 30-day period, Grantee may resign based on the Good Reason condition specified in the notice effective no later than 30 days following the expiration of the 30-day cure period.

 

5.             Procedure for Exercise and Payment of Exercise Price.  Grantee may exercise all or any portion of the Option, to the extent it is vested and outstanding, at any time prior to its expiration, by (i) delivering a properly executed written notice of exercise to the Company, in such form as shall be approved by the Company, specifying the number of Option Shares to be purchased, and (ii) paying to the Company the aggregate Exercise Price of the Option Shares to be purchased. Grantee shall pay the aggregate Exercise Price of the Option Shares to be purchased on exercise of the Option (i) by payment of such aggregate Exercise Price in cash or by certified or bank cashier’s check payable to the order of the Company, (ii) by delivery of irrevocable instructions to a stockbroker to sell immediately some or all of the Option Shares acquired by exercise of the Option and to promptly deliver to the Company an amount of the sale proceeds sufficient to pay the aggregate Exercise Price, or (iii) in the discretion of the Committee, by such other cashless means authorized by Paragraph 6(g) of the Plan.

 

6.             Termination of Employment.  Upon termination of Grantee’s employment with the Company or a Subsidiary for any reason (other than as set forth in Paragraph 4 above), vesting of the Option shall terminate and any portion of the Option that is unvested at the time of termination of Grantee’s employment with the Company or a Subsidiary shall expire, terminate and be forfeited and of no further force or effect. If the Company or a Subsidiary terminates Grantee’s employment for Cause, any portion of the Option which is vested at the time of such termination shall also expire, terminate and be forfeited and of no further force or effect. If Grantee’s employment with the Company or a Subsidiary terminates due to the death or Disability of Grantee, any portion of the Option that is vested on the date of such termination may be exercised only during the one year period following such termination, but in no event after the Expiration Date. If Grantee’s employment with Company or a Subsidiary terminates for any reason other than death, Disability or Cause, or as set forth in Paragraph 4 above, any portion of the Option that is vested on the date of such termination may be exercised only during the 90 day period following such termination, but in no event after the Expiration Date.

 

2

 

7.             Non-Transferability of Option.  The Option is personal to Grantee. Unless permitted otherwise in the discretion of the Committee, the Option is not transferable by Grantee (other than by will or the laws of descent and distribution) and, during Grantee’s lifetime, only Grantee (or his guardian or legal representative) may exercise the Option. In the event of Grantee’s death, the Option may be exercised (i) by the executor or administrator of Grantee’s estate or the person or persons to whom Grantee’s rights under the Option shall pass by will or the laws of descent and distribution, and (ii) to the extent and during the period Grantee was allowed to exercise the Option at the date of Grantee’s death.

 

8.             Restrictive Covenants; Compensation Recovery.  By signing this Agreement, Grantee acknowledges and agrees that the Option and the Option Shares (and any stock or stock-based award previously granted by the Company or a Subsidiary to Grantee under the Plan or otherwise) shall (i) be subject to forfeiture as a result of Grantee’s violation of any agreement with the Company or a Subsidiary regarding non-competition, non-solicitation, confidentiality, non-disparagement, inventions and/or similar restrictive covenants (the “Restrictive Covenants Agreement”), and (ii) be subject to forfeiture and/or recovery under any compensation recovery policy that may be adopted from time to time by the Company or any of its Subsidiaries. For avoidance of doubt, compensation recovery rights to the Option Shares or other shares of Company stock (including shares of stock acquired under previously granted stock-based awards) shall extend to the proceeds realized by Grantee due to sale or other transfer of such stock. Grantee’s prior execution of the Restrictive Covenants Agreement was a material inducement for the Company’s grant of the Option under this Agreement.

 

9.             Conformity with Plan.  The Option is intended to conform in all respects with and is subject to all applicable provisions of the Plan, which is incorporated herein by reference. Any inconsistencies between the provisions of this Agreement and the Plan shall be resolved in accordance with the provisions of the Plan.

 

10.          Rights as a Participant.  Nothing contained in this Agreement shall (i) interfere with or limit in any way the right of the Company or a Subsidiary to terminate Grantee’s employment at any time and for any or no reason, (ii) confer upon Grantee any right to be selected again as a Plan Participant, or (iii) require or permit any adjustment to the number of Option Shares or to the Exercise Price upon or as a result of the occurrence of any subsequent event (except as provided in Paragraph 13 of the Plan).

 

11.          Withholding of Taxes.  Any income or employment tax required to be withheld upon exercise of the Option shall be paid by Grantee to the Company or a Subsidiary (whichever is the employer of Grantee), or the Company or a Subsidiary (whichever is the employer of Grantee) may withhold such tax from the cash compensation otherwise payable to Grantee. Alternatively, Grantee may pay any such withholding tax (i) by delivery of irrevocable instructions to a stockbroker to sell immediately some or all of the Option Shares acquired by exercise of the Option and to promptly deliver to the Company an amount of the sale proceeds sufficient to pay the withholding tax due on exercise of the Option, or (ii) such other cashless means as may be permitted under law and in the discretion of the Committee.

 

3

 

12.          Resale Restrictions.  The Company currently has an effective registration statement on file with the Securities and Exchange Commission with respect to the Option Shares. The Company currently intends to maintain this registration, but has no obligation to do so. If the registration ceases to be effective, Grantee will not be able to sell or transfer Option Shares issued to Grantee upon exercise of the Option unless an exemption from registration under applicable securities laws is available. Grantee agrees that any resale by Grantee of Option Shares acquired upon exercise of the Option shall comply in all respects with the requirements of all applicable securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act of 1933, as amended, the Exchange Act, and the respective rules and regulations promulgated thereunder) and any other law, rule or regulation applicable thereto, as such laws, rules and regulations may be amended from time to time. The Company shall not be obligated to issue the Option Shares or permit their resale if such issuance or resale would violate any such requirements.

 

13.          Consent to Transfer of Personal Data.  In administering this Agreement and the Plan, or to comply with applicable legal, regulatory, tax or accounting requirements, it may be necessary for the Company to transfer certain Grantee personal data to a Subsidiary, or to outside service providers, or to governmental agencies. By signing this Agreement and accepting the award of the Option, Grantee consents, to the fullest extent permitted by law, to the use and transfer, electronically or otherwise, of Grantee’s personal data to such entities for such purposes.

 

14.          Consent to Electronic Delivery.  In lieu of receiving documents in hard copy paper format, Grantee agrees, to the fullest extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, but not limited to, prospectuses, prospectus supplements, grant or award notifications and agreements, account statements, annual and quarterly reports, and all other agreements, documents, forms and communications) in connection with the Option and any other prior or future incentive award or program made or offered by the Company, a Subsidiary and their predecessors or successors. Electronic delivery of a document to Grantee may be via a Company or Subsidiary email system or by reference to a location on a Company or Subsidiary intranet site to which Grantee has access.

 

15.          No Ownership of Option Shares Until Exercise.  Prior to the Grantee’s exercise of the Option and purchase of the Option Shares, the Grantee shall not possess any incidents of ownership of the Option Shares, including voting or dividend rights.

 

16.          Notices.  Any and all notices, designations, consents, offers, acceptances and any other communications provided for herein shall be given in writing and shall be delivered either personally or by registered or certified mail, postage prepaid, which shall be addressed, in the case of the Company, to the Chief Financial Officer of the Company at the principal office of the Company and, in the case of the Grantee, to the Grantee’s address appearing on the books of the Company or to such other address as may be designated in writing by the Grantee.

 

17.          Successors.  The terms of this Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns, and of the Grantee and the beneficiaries, executors, administrators, heirs and successors of the Grantee.

 

4

 

18.          Invalid Provision.  The invalidity or unenforceability of any particular provision hereof shall not affect the other provisions hereof, and this Agreement shall be construed in all respects as if such invalid or unenforceable provision had been omitted.

 

19.          Modifications.  Except as provided in the Plan, no change, modification or waiver of any provision of this Agreement shall be valid unless the same is in writing and signed by the parties hereto.

 

20.          Entire Agreement.  This Agreement and the Plan contain the entire agreement and understanding of the parties hereto with respect to the subject matter contained herein and therein and supersede all prior communications, representations and negotiations in respect thereto.

 

21.          Governing Law.  This Agreement and the rights of the Grantee hereunder shall be governed, construed, and administered in accordance with and governed by the laws of the State of Michigan (regardless of the laws that might otherwise govern under applicable principles of conflicts of laws of such jurisdiction or any other jurisdiction).

 

22.          Headings.  The headings of the Paragraphs hereof are provided for convenience only and are not to serve as a basis for interpretation or construction, and shall not constitute a part, of this Agreement.

 

23.          Counterparts.  This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

24.          Committee Determinations Final and Binding.  The Committee shall have final authority to interpret and construe the Plan and this Agreement and to make any and all determinations thereunder, and its decision shall be binding and conclusive upon the Grantee and his/her legal representative in respect of any questions arising under the Plan or this Agreement.

 

[signature page follows]

 

5

 

	
 
    	
Diplomat   Pharmacy, Inc.
    
	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
By:
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
Name:
    	
 
    
	
 
    	
Its:
    	
 
    

 

The undersigned hereby acknowledges having read this Agreement and the Plan and agrees to be bound by all provisions set forth herein and in the Plan.

 

	
 
    	
 
    
	
Dated   as of:
    	
 
    	
 
    	
GRANTEE:
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
Name:
    	
 
    
					

 

6Exhibit 10.28

  

Creative
Medical Technology Holdings, Inc.

 

CODE
OF BUSINESS CONDUCT AND ETHICS

 

		1.	Introduction

 

This Code of Business
Conduct and Ethics (this “Code”) has been adopted by our board of directors (the “Board of Directors”)
to summarize the standards of business conduct that must guide our actions. This Code applies to all directors, officers, and employees
of Creative Medical Technology Holdings, Inc. and its subsidiaries (the “Company”), including, but not limited
to, the Company’s principal executive officer, principal financial officer, principal accounting officer or controller, or
persons performing similar functions. The Company has issued this Code to deter wrongdoing and to promote:

		·	honest and ethical conduct;

		·	full, fair, accurate, timely, and understandable disclosure
in reports and documents that a registrant files with, or submits to, the Securities and Exchange Commission (the “SEC”)
and in other public communications made by the Company;

		·	avoidance and ethical handling of actual or apparent
conflicts of interest, including disclosure to an appropriate person of any material transaction or relationship that reasonably
could be expected to give rise to such a conflict;

		·	confidentiality of corporate information;

		·	protection and proper use of corporate assets and opportunities;

		·	compliance with applicable governmental laws, rules,
and regulations;

		·	prompt internal reporting of any violations of this
Code to an appropriate person; and

		·	accountability for adherence to the Code.

 

This Code provides guidance
to you on your ethical and legal responsibilities. We expect all directors, officers, and employees to comply with this Code, and
the Company is committed to taking prompt and consistent action against violations of this Code. Violation of the standards outlined
in this Code may be grounds for disciplinary action up to and including termination of employment or other business relationships.
Employees, officers and directors who are aware of suspected misconduct, illegal activities, fraud, abuse of the Company’s
assets, or violations of the standards outlined in this Code are responsible for reporting such matters.

 

Because rapid changes
in our industry and regulatory environment constantly pose new ethical and legal considerations, no set of guidelines should be
considered to be the absolute last word under all circumstances. Although laws and customs will vary in the different countries
in which we operate, our basic ethical responsibilities are global. In some instances, there may be a conflict between the laws
of countries that apply to the operations of the Company. When you encounter such a conflict, you should consult the Company’s
senior management and/or legal counsel to understand how to resolve that conflict properly.

 

		2.	Basic Obligations

 

Under the Company’s
ethical standards, directors, officers, and employees share certain responsibilities. It is your responsibility to (i) become familiar
with, and conduct Company business in compliance with applicable laws, rules, and regulations and this Code; (ii) treat all Company
employees, customers, and business partners in an honest and fair manner; (iii) avoid situations where your personal interests
are, or appear to be, in conflict with the Company interests; and (iv) safeguard and properly use the Company’s proprietary
and confidential information, assets, and resources, as well as those of the Company’s customers and business partners.

 

    	 

    	 

    

Certain of the Company’s
policies may be complemented by specific responsibilities set forth in documents subsequently adopted by the Company such as the
Company’s Confidential Information Policy, an insider trading policy, a disclosure policy, a cybersecurity policy, etc.
Those polices should be separately consulted by the Company’s directors, officers, and employees and are not incorporated
by reference into this Code.

 

		3.	Raising Concerns

 

If you should learn of
a potential or suspected violation of this Code, you have an obligation to promptly report the violation. You may do so orally
or in writing and, if preferred, anonymously. You have several options for raising concerns.

 

		1.	Raise your concerns with your supervisor or manager;

		2.	Raise your concerns with the Company’s Chief
Executive Officer and/or

		3.	Company legal counsel.

 

If the issue or concern
is related to the internal accounting controls of the Company or any accounting or auditing matter, you should report it to the
Chief Financial Officer.

 

		4.	Policy Against Retaliation

 

The Company prohibits
any director or employee from retaliating or taking adverse action against anyone for raising, in good faith, suspected conduct
violations or helping to resolve a conduct concern. Any individual who has been found to have engaged in retaliation against a
Company director, officer or employee for raising, in good faith, a conduct concern or for participating in the investigation of
such a concern, may be subject to discipline, up to and including termination of employment or other business relationships. If
any individual believes that he or she has been subjected to such retaliation, that person is encouraged to report the situation
as soon as possible to one of the people detailed in the “Raising Concerns” section above.

 

		5.	Conflicts of Interest

 

Directors, officers,
and employees should not engage in any activity, practice or act which conflicts with the best interests of the Company. A conflict
of interest occurs when a director, officer or employee places or finds himself/herself in a position where his/her private interests
conflict with the best interests of the Company or have an adverse effect on the person’s motivation or the proper performance
of their office or job. Examples of such conflicts could include, but are not limited to:

		·	accepting outside employment with, or accepting personal
payments from, any organization which does business with the Company or is a competitor of the Company;

		·	accepting or giving gifts of more than modest value
to or from vendors or clients of the Company;

		·	competing with the Company for the purchase or sale
of property, services or other interests or taking personal advantage of an opportunity in which the Company has an interest;

		·	personally having immediate family members who have
a financial interest in a firm which does business with the Company; and

		·	having an interest in a transaction involving the Company
or a customer, business partner or supplier (not including routine investments in publicly traded companies).

 

Directors, officers,
and employees must not place themselves or remain in a position in which their private interests conflict with the interests of
the Company. Knowledge of any potential conflict of interest must be reported as soon as possible to one of the people detailed
in the “Raising Concerns” section above.

 

    	 

    	 

    

If the Company determines
that the outside work or other relationship of an officer, director or employee interferes with performance or the ability to meet
the requirements of the Company, as they are modified from time to time, the party may be asked to terminate the outside employment
or other relationship if he or she wishes to remain employed by the Company or as an officer or director of the Company. To protect
the interests of both the officers, directors, and employees and the Company, any such outside work or other activity that involves
potential or apparent conflict of interest may be undertaken only after disclosure to the Company by the party and review and approval
by management.

 

		6.	Confidentiality Concerning Company Affairs

 

It is the Company’s
policy that business affairs of the Company are confidential and should not be discussed with anyone outside the organization except
for information that has already been made available to the public. See the Company’s “Confidential Information
Policy” for more detail.

 

		7.	Competition and Fair Dealing

 

We seek to out-perform
our competition fairly and honestly. We seek competitive advantages through superior performance, not through unethical or illegal
business practices. Information about other companies and organizations, including competitors, must be gathered using appropriate
methods. Illegal practices such as trespassing, burglary, misrepresentation, wiretapping, and stealing are prohibited. Possessing
trade secrets that were obtained without the owner’s consent, or inducing such disclosures by customers or past or present
employees of other companies is prohibited. Each employee and officer should endeavor to respect the rights of, and deal fairly
with, our customers, suppliers, competitors, and employees. No employee, officer or director should take unfair advantage of anyone
through manipulation, concealment, abuse of privileged information, misrepresentation of material facts, or any other unfair business
practice.

 

		8.	Insider Trading

 

The Company encourages
all employees to become shareholders on a long-term investment basis. However, management, employees, members of the Board of Directors
and others who are in a “special relationship” with the Company from time to time, may become aware of corporate developments
or plans which may affect the value of the Company’s shares (inside information) before these developments or plans are made
public. Blackout periods may be imposed during certain times throughout the year and during this time, all Company employees, officers
and directors are prohibited from buying or selling the Company’s securities. In order to avoid civil and criminal insider
trading violations, the Company may establish an insider trading policy.

 

		9.	Telecommunications

 

Telecommunications facilities
such as telephone, cellular phones, facsimile, internet, and email are the Company property. Use of these facilities imposes certain
responsibilities and obligations on all employees, officers and directors. Usage must be ethical and honest with a view to preservation
of and due respect for the Company’s intellectual property, security systems, personal privacy, and freedom of others from
intimidation, harassment, or unwanted annoyance.

 

		10.	Accuracy of Company Records

 

We are required to record
and, in certain instances, publicly report all internal and external financial records in compliance with U.S. Generally Accepted
Accounting Principles (GAAP) and the rules and regulations of the Securities and Exchange Commission (the “SEC”).
Therefore, you are responsible for ensuring the accuracy of all books and records within your control and complying with all of
the Company’s policies and internal controls.

 

    	 

    	 

    

All
Company information must be reported accurately, whether in internal personnel, safety, or other records or in information we
release to the public or file with government agencies.

 

		11.	Financial Reporting and Disclosure Controls

 

If in the future we are
required to file periodic and other reports with the SEC and other securities regulators and to make certain public communications,
we will be required to maintain effective “disclosure controls and procedures” so that financial and non-financial
information is reported timely and accurately both to our senior management and in the filings we make. You are expected, within
the scope of your employment duties, to support the effectiveness of our disclosure controls and procedures.

 

		12.	Customers and Business Partners

 

We strive to achieve
satisfied customers who will be repeat buyers of our products and services and to building mutually advantageous alliances with
our business partners.

 

Our long-term reputation
and business viability depend upon our continued maintenance of the high quality of the products and services we provide. We are
committed to delivering products that perform as documented and as represented to the customer.

 

Our policy is to build
lasting relationships with our customers and business partners through superior delivery and execution and honest sales and marketing.
We will comply with applicable advertising laws and standards, including a commitment that our advertising and marketing will be
truthful, non-deceptive, and fair and will be backed up with evidence before advertising claims are made. Our policy also prohibits
making false or deceptive statements about our competitors and giving or accepting kickbacks, bribes, inappropriate gifts and other
matters prohibited under the conflict of interest topic in this Code.

 

		13.	Health and Safety

 

The Company is committed
to making the work environment safe, secure, and healthy for its employees and others. The Company complies with all applicable
laws and regulations relating to safety and health in the workplace. We expect each of you to promote a positive working environment
for all. You are expected to consult and comply with all Company rules regarding workplace conduct and safety. You should immediately
report any unsafe or hazardous conditions or materials, injuries, and accidents connected with our business and any activity that
compromises Company security to your supervisor. You must not work under the influence of any substances that would impair the
safety of others. All threats or acts of physical violence or intimidation are prohibited.

 

		14.	Respect for Our Employees

 

The Company’s employment
decisions will be based on reasons related to our business, such as job performance, individual skills and talents, and other business-related
factors. The Company policy requires adherence to all national, provincial or other local employment laws. In addition to any other
requirements of applicable laws in a particular jurisdiction, the Company policy prohibits discrimination in any aspect of employment
based on race, color, religion, sex, national origin, disability, age or gender orientation, within the meaning of applicable laws.

 

		15.	Abusive or Harassing Conduct Prohibited

 

The Company policy prohibits
abusive or harassing conduct by our employees and officers toward others, such as unwelcome sexual advances, comments based on
ethnicity, religion, gender orientation, or race, or other non-

 

    	 

    	 

    

business,
personal comments or conduct that make others uncomfortable in their employment with us. We encourage and expect you to report
harassment or other inappropriate conduct as soon as it occurs.

 

		16.	Privacy

 

The Company, and companies
and individuals authorized by the Company, collect and maintain personal information that relates to your employment, including
compensation, medical and benefit information. The Company follows procedures to protect information wherever it is stored or processed,
and access to your personal information is restricted. Your personal information will only be released to outside parties in accordance
with the Company’s policies and applicable legal requirements. Employees, officers and directors who have access to personal
information must ensure that personal information is not disclosed in violation of the Company’s policies or practices.

 

		17.	Waivers and Amendments

 

Only the Board of Directors
may waive application of or amend any provision of this Code. A request for such a waiver should be submitted in writing to the
Board of Directors for its consideration. The Company will promptly disclose to investors all substantive amendments to the Code,
as well as all waivers of the Code granted to directors or officers in accordance with applicable laws and regulations.

 

		18.	No Rights Created

 

This Code is a statement
of the fundamental principles and key policies and procedures that govern the conduct of our business. It is not intended to and
does not, in any way, constitute an employment contract or an assurance of continued employment or create any rights in any employee,
director, client, supplier, competitor, stockholder or any other person or entity.

 

Any change or waiver
to this Code may be made only by the Board of Directors and will be promptly disclosed as required by law or regulation.

 

[Adopted by the Board
of Directors on May 18, 2016]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00281-of-00352.parquet"}]]